Endocrinology, Diabetes & Metabolism Doctors in Montana Medicare Details, Address, Contact
15 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 15
 Ms. Lauren Elizabeth Kleess, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1045 N 30th St, Billings, MT 59101 Phone: 406-238-2500 |
 James A. Mack, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1045 N 30th St, Billings, MT 59101 Phone: 406-238-2500 |
Dr. Reed Stanton Christensen, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1045 N 30th St, Department Of Diabetes And Endocrinology, Billings, MT 59101 Phone: 406-238-2500 |
Christopher H. Sorli, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1045 N 30th St, Billings, MT 59101 Phone: 406-238-2500 |
David F. Johnson, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1045 N 30th St, Billings, MT 59101 Phone: 406-238-2500 |
Brian G Rose, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 935 Highland Blvd Ste 2180, Bozeman, MT 59715 Phone: 406-414-5331 Fax: 406-414-5332 |
Heidi Peynado De Pena, Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8318 |
Dr. Barry William Cohan, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1400 29th St S, Great Falls, MT 59405 Phone: 406-454-2171 |
Dr. Alison E Schneider, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 430 Windward Way Ste 100, Kalispell, MT 59901 Phone: 406-751-5364 Fax: 406-751-5367 |
Jose C De Souza, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 430 Windward Way Ste 100, Kalispell, MT 59901 Phone: 406-751-5364 Fax: 406-751-5367 |
Michele A Danicich, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802 Phone: 406-329-5781 Fax: 406-327-3331 |
Christopher M Corsi, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802 Phone: 406-329-5781 Fax: 406-327-3331 |
Meredith F Ross, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802 Phone: 406-329-5781 Fax: 406-327-3331 |
Dr. Rino Alberto Buzzola, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802 Phone: 406-329-5781 Fax: 406-327-3331 |
Dr. Ruth Louise Sampson, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 403 S 4th St W, Missoula, MT 59801 Phone: 406-728-1985 Fax: 406-728-2272 |
News Archive
Kaiser Permanente researchers named co-recipients of Drug Therapy Research Literature Award
Three Kaiser Permanente Colorado researchers have been named co-recipients of the prestigious Drug Therapy Research Literature Award, an award presented annually by the American Society of Health-System Pharmacists Foundation.
Isis announces top-line results from ISIS-PTP1B Rx Phase 2 study in type 2 diabetes patients
Isis Pharmaceuticals, Inc. announced today top-line results from a Phase 2 study of ISIS-PTP1B Rx in patients with type 2 diabetes. In the Phase 2 study patients treated with ISIS-PTP1B Rx achieved statistically significant reductions in body weight and hemoglobin A1c (HbA1c).
Amorfix, Aragen Bioscience collaborate to develop high-affinity monoclonal antibodies against targets for cancer
Amorfix Life Sciences and Aragen Bioscience, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Using its proprietary ProMIS(TM) computational platform discovery technology, Amorfix has identified several disease specific epitopes ("DSEs") on misfolded Fas receptor. Aragen will use those DSEs to generate highly specific monoclonal antibodies ("mAbs").
Scientists show how absence of microbiota has remarkable effect against obesity
In the past few years, research on gut microbiota (that is, all microorganisms, mainly bacteria, inhabiting our gut) has started to unravel its tremendous role in our body, and how it symbiotically affects the functioning of our organs. In particular, microbiota has also an impact on the way calories are absorbed and how fat cells develop.
› Verified 3 days ago